AmerisourceBergen gets Express Scripts job; Catalent likes single-use reactors;

> AmerisourceBergen ($ABC) has been tapped to be the drug distributor for pharmaceutical benefit manager Express Scripts ($ESRX) beating out Cardinal Health ($CAH). Story

> Catalent has replaced its stainless steel bioreactors at its biologics facility in Middleton, WI, with disposable technology. Story

> Alnylam Pharmaceuticals received a $3.2 million milestone payment from GlaxoSmithKline ($GSK) for new manufacturing technology for a GSK vaccine. Item

> Granules India reports higher sales as demand from China drove its API business. Story

> A congressional report says some U.S. pharmacies are selling all of their inventories into the gray market at huge markups. Story

And Finally... Canada is looking at establishing a bidding process to buy generics nationally in hopes of getting them cheaper. Story

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.